Strata Critical Medical (SRTA) Leases (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Leases data on file, last reported at $4.2 million in Q1 2026.

• Quarterly Leases fell 51.5% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 51.5% YoY) and the FY2025 annual result came in at $3.1 million, up 9.75% from the prior year.
• Leases improved to $4.2 million in Q1 2026 per SRTA's latest filing, from $3.1 million in the prior quarter.
• Across five years, Leases topped out at $24.6 million in Q1 2024 and bottomed at $958000.0 in Q1 2022.
• The 5-year median for Leases is $16.9 million (2022), against an average of $13.8 million.
• The widest annual swing landed in 2022, when Leases soared 2490.83%; it then plunged 87.94% in 2024.
• Tracing SRTA's Leases over 5 years: stood at $17.7 million in 2022, then surged by 32.74% to $23.5 million in 2023, then sank by 87.94% to $2.8 million in 2024, then climbed by 9.75% to $3.1 million in 2025, then jumped by 35.02% to $4.2 million in 2026.
• Per Business Quant, the three latest SRTA Leases figures stand at $4.2 million (Q1 2026), $3.1 million (Q4 2025), and $3.3 million (Q3 2025).

Peer Comparison